COMPARISON OF ALLELE AND GENOTYPE FREQUENCIES OF THE UMOD GENE POLYMORPHISM RS4293393 BETWEEN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS AND A CONTROL GROUP
Keywords:
UMOD gene, rs4293393, chronic glomerulonephritis, allele frequency, genotype distribution, polymorphism, genetic association, risk assessmentAbstract
This study focuses on the comparative analysis of allele and genotype frequencies of the UMOD gene polymorphic marker rs4293393 in patients with chronic glomerulonephritis (CGN) and a control group. The aim is to identify potential associations between allelic variants and the risk of CGN. Data collection and analysis revealed the distribution of alleles C and T among patients and controls. Allele C was found more frequently in patients with CGN than in the control group (30.91% vs. 25.84%, OR = 1.28, 95% CI: 0.80–2.05), though statistical significance was not achieved (p = 0.356). Conversely, allele T was less frequent among patients (69.09% vs. 74.16%, OR = 0.78, 95% CI: 0.49–1.24), also without statistical significance (p = 0.356). The results suggest a weak association between the UMOD rs4293393 polymorphism and CGN risk, warranting further research for confirmation.References
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013 Sep;84(3):1-150.
Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011 Dec;80(12):1258-70. doi: 10.1038/ki.2011.368. Epub 2011 Oct 12.
Bellomo G., Venanzi S., Verdura C. et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis 2010; 56:264.
Johnson RJ, Nakagawa T, Jalal D, et al. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant. 2013 Sep;28(9):2221-8. doi: 10.1093/ndt/gft029. Epub 2013 Mar 29.
Kang DH, Chen W. Uric acid and chronic kidney disease: new understanding of an old problem. Semin Nephrol. 2011 Sep;31(5):447- 52. doi: 10.1016/j.semnephrol.2011.08.009.
Kratzer JT, Lanaspa MA, Murphy MN, et al. Evolutionary history and metabolic insights of ancient mammalian uricases. Proc Natl Acad Sci US A. 2014 Mar 11;111(10): 3763-8. doi: 10.1073/pnas.1320393111. Epub 2014 Feb 18.
Alimjanovich , R. Z., Maxammatkulovich , R. N., & Khikmatovich , K. K. (2022). Age Features of the Prevalence of Prostate Cancer in Uzbekistan. Central Asian Journal of Medical and Natural Science, 3(5), 154-157. Retrieved from
Rizaev Jasur , Rakhimov Nodir , Kodyrov Khamidullo , Shakhanova Shakhnoza . Study of prostate cancer death by regions of the republic of Uzbekistan.Journal of Biomedicine and Practice. 2022, vol . 7, issue 5, pp.202-210
Nodir RM, Shaxnoza SS, Farhod R. Development of new approaches in the treatment of metastatic renal cell carcinoma //Journal of research in health science. – 2020. – T. 5. – no. 4. – pp. 82-95.
ShSh Shakhanova , NM Rakhimov. Multimodal approach to the treatment of multiple osteogenic metastases of kidney and prostate cancer . Clinical and Experimental Oncology 2020, No. 4 Page 50-56.
Richette P, Latourte A, Bardin T. Cardiac and renal protective effects of uratelowering therapy. Rheumatology (Oxford). 2018 Jan 1; 57(suppl_1):i47-i50. doi: 10.1093/rheumatology/kex432.
Paul BJ, Anoopkumar K, Krishnan V. Asymptomatic hyperuricemia: is it time to intervene? Clin Rheumatol. 2017 Dec;36(12): 2637-2644. doi: 10.1007/s10067-017-3851-y. Epub 2017 Oct
